Q VYJUVEK revenue and $623.2 million since U.S. launch VYJUVEK launched in Germany in 3Q; launched in France and Japan in 4Q Updated U.S. VYJUVEK label expands eligible patient population and provides ...
The biotechnology market is entering a new growth phase, driven by the convergence of genomic science, artificial intelligence, and precision medicine.
Amazon S3 on MSN
Marketing firms are developing technology to influence dreams
Dream hacking technology can alter or control dreams, with potential applications in therapy, education, and creativity, but ...
The company believes the Food and Drug Administration may deal a setback to one of its investigational therapies.
Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today that the U.S. Food and Drug ...
The Third Economic Forum on Genetic Resources, titled ‘GenoBusiness Forum’, highlighted the fundamentals of natural resources in Dhofar and called for necessary innovation to tap the resources. The ...
Dr. Andrea Toulouse launched the 3DEndoFab project, which aims to develop a micro 3D printer that can be integrated into the ...
An expanded soybean portfolio, new herbicide formulation and a new trait on the near horizon are flowing through the pipeline ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback